BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36038418)

  • 1. Self-assembled flagella protein nanofibers induce enhanced mucosal immunity.
    Fu D; Wang M; Yang T; Li M; Liang Z; Chen C; Zhang L; Xue C; Sun B; Mao C
    Biomaterials; 2022 Sep; 288():121733. PubMed ID: 36038418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB.
    Verma V; Tan W; Puth S; Cho KO; Lee SE; Rhee JH
    J Transl Med; 2016 May; 14(1):135. PubMed ID: 27184355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection.
    Hong SH; Byun YH; Nguyen CT; Kim SY; Seong BL; Park S; Woo GJ; Yoon Y; Koh JT; Fujihashi K; Rhee JH; Lee SE
    Vaccine; 2012 Jan; 30(2):466-74. PubMed ID: 22051136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
    Patel GB; Zhou H; Ponce A; Chen W
    Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen replacement of domains D2 and D3 in flagellin promotes mucosal IgA production and attenuates flagellin-induced inflammatory response after intranasal immunization.
    Yang J; Zhong M; Zhang Y; Zhang E; Sun Y; Cao Y; Li Y; Zhou D; He B; Chen Y; Yang Y; Yu J; Yan H
    Hum Vaccin Immunother; 2013 May; 9(5):1084-92. PubMed ID: 23377752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.
    Strindelius L; Filler M; Sjöholm I
    Vaccine; 2004 Sep; 22(27-28):3797-808. PubMed ID: 15315861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant.
    Nyström S; Bråve A; Falkeborn T; Devito C; Rissiek B; Johansson DX; Schröder U; Uematsu S; Akira S; Hinkula J; Applequist SE
    Vaccines (Basel); 2013 Sep; 1(4):415-43. PubMed ID: 26344341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of Antigen Adjuvanted with AS04 and Its Deposition in the Upper Respiratory Tract after Intranasal Administration.
    Xu H; Alzhrani RF; Warnken ZN; Thakkar SG; Zeng M; Smyth HDC; Williams RO; Cui Z
    Mol Pharm; 2020 Sep; 17(9):3259-3269. PubMed ID: 32787271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal Vaccination With Recombinant
    Wei J; Hegde VL; Yanamandra AV; O'Hara MP; Keegan B; Jones KM; Strych U; Bottazzi ME; Zhan B; Sastry KJ; Hotez PJ
    Front Immunol; 2022; 13():800295. PubMed ID: 35197976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal immunization with a flagellin-adjuvanted Hgp44 vaccine enhances protective immune responses in a murine Porphyromonas gingivalis infection model.
    Puth S; Hong SH; Park MJ; Lee HH; Lee YS; Jeong K; Kang IC; Koh JT; Moon B; Park SC; Rhee JH; Lee SE
    Hum Vaccin Immunother; 2017 Dec; 13(12):2794-2803. PubMed ID: 28604268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLRC4 Inflammasome-Driven Immunogenicity of a Recombinant MVA Mucosal Vaccine Encoding Flagellin.
    Sanos SL; Kassub R; Testori M; Geiger M; Pätzold J; Giessel R; Knallinger J; Bathke B; Gräbnitz F; Brinkmann K; Chaplin P; Suter M; Hochrein H; Lauterbach H
    Front Immunol; 2017; 8():1988. PubMed ID: 29416534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmonella flagellin enhances mucosal immunity of avian influenza vaccine in chickens.
    Chaung HC; Cheng LT; Hung LH; Tsai PC; Skountzou I; Wang B; Compans RW; Lien YY
    Vet Microbiol; 2012 May; 157(1-2):69-77. PubMed ID: 22226542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant flagellins with deletions in domains D1, D2, and D3: Characterization as novel immunoadjuvants.
    Biedma ME; Cayet D; Tabareau J; Rossi AH; Ivičak-Kocjan K; Moreno G; Errea A; Soulard D; Parisi G; Jerala R; Berguer P; Rumbo M; Sirard JC
    Vaccine; 2019 Jan; 37(4):652-663. PubMed ID: 30583910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gold nanoparticles conjugating recombinant influenza hemagglutinin trimers and flagellin enhanced mucosal cellular immunity.
    Wang C; Zhu W; Luo Y; Wang BZ
    Nanomedicine; 2018 Jun; 14(4):1349-1360. PubMed ID: 29649593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity.
    Lee SE; Kim SY; Jeong BC; Kim YR; Bae SJ; Ahn OS; Lee JJ; Song HC; Kim JM; Choy HE; Chung SS; Kweon MN; Rhee JH
    Infect Immun; 2006 Jan; 74(1):694-702. PubMed ID: 16369026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR7 and 9 agonists are highly effective mucosal adjuvants for norovirus virus-like particle vaccines.
    Hjelm BE; Kilbourne J; Herbst-Kralovetz MM
    Hum Vaccin Immunother; 2014; 10(2):410-6. PubMed ID: 24280723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations.
    Cristillo AD; Ferrari MG; Hudacik L; Lewis B; Galmin L; Bowen B; Thompson D; Petrovsky N; Markham P; Pal R
    J Gen Virol; 2011 Jan; 92(Pt 1):128-40. PubMed ID: 21169215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin.
    Vijay-Kumar M; Carvalho FA; Aitken JD; Fifadara NH; Gewirtz AT
    Eur J Immunol; 2010 Dec; 40(12):3528-34. PubMed ID: 21072873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 12 and innate molecules for enhanced mucosal immunity.
    Boyaka PN; Lillard JW; McGhee J
    Immunol Res; 1999; 20(3):207-17. PubMed ID: 10741861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity.
    Henderson A; Propst K; Kedl R; Dow S
    Vaccine; 2011 Jul; 29(32):5304-12. PubMed ID: 21600950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.